Read now on mcall.com • September 7, 2019
Category: Saladax Biomedical
Saladax develops first-ever rapid test for an antipsychotic drug using a single drop of blood to aid psychiatrists in the treatment of schizophrenia
Read now on BusinessWire.com • September 5, 2019
Saladax Biomedical gets CE mark for antipsychotic drug POC Test
Read now on 360dx.com • September 5, 2019
Saladax Biomedical welcomes new guidelines from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) for 5-Fluorouracil therapy
Read now on BusinessWire.com • September 19, 2018
Saladax Biomedical submits antipsychotic drug test for FDA review
Read now on 360dx.com • July 17, 2018
Bethlehem biotech company to acquire exclusive patent rights to antipsychotic drug tests
Read now on LVB.com • June 28, 2018
Bethlehem biotech company Saladax signs licensing deal with Johnson & Johnson affiliate
Read now on MCall.com • June 28, 2018
